Literature DB >> 17606298

Specific type of interactions in the quaternary system of Cu(II), adenosine 5'-triphosphate, 1,11-diamino-4,8-diazaundecane and uridine.

Anna Gasowska1, Renata Jastrzab, Lechoslaw Lomozik.   

Abstract

Complexation reactions in the quaternary system Cu/ATP/3,3,3-tet/Urd have been studied. The stability constants of the complexes of the Cu(ATP)(3,3,3-tet)H(x)(Urd) type have been determined by computer analysis of the potentiometric titration. On the basis of the results of spectroscopic as well as equilibrium studies, the mode of interactions has been proposed. Metal ions coordinate phosphate groups of ATP and nitrogen atoms of polyamine. It has been established that in the conditions of the complex Cu(ATP)(3,3,3-tet) formation, uridine introduced into the Cu(II)/ATP/3,3,3-tet ternary system is involved in hydrogen bonding with the endocyclic nitrogen atoms N(1) and N(7) of the ATP purine ring and formation of the adduct Cu(ATP)(3,3,3-tet)H(Urd) is observed. Introduction of metal ions into the system changes substantially the mode of interactions between complementary base pairs relative to that proposed in the Watson and Crick model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17606298     DOI: 10.1016/j.jinorgbio.2007.05.009

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  2 in total

1.  Coordination Reactions and Noncovalent Interactions of Polyamines with Nucleotides in Binary Systems and with Nucleotides and Copper(II) Ion in Ternary Systems.

Authors:  Lechoslaw Lomozik; Anna Gasowska; Grzegorz Krzysko; Romualda Bregier-Jarzebowska
Journal:  Bioinorg Chem Appl       Date:  2010-09-05       Impact factor: 7.778

2.  Thermodynamic and Spectroscopic Studies of the Complexes Formed in Tartaric Acid and Lanthanide(III) Ions Binary Systems.

Authors:  Michal Zabiszak; Martyna Nowak; Zbigniew Hnatejko; Jakub Grajewski; Kazuma Ogawa; Malgorzata T Kaczmarek; Renata Jastrzab
Journal:  Molecules       Date:  2020-03-03       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.